A PLACEBO CONTROLLED TRIAL OF BUSPIRONE FOR THE TREATMENT OF MARIJUANA DEPENDENCE
I tiakina i:
MCRAE, A.L., ET AL., A PLACEBO CONTROLLED TRIAL OF BUSPIRONE FOR THE TREATMENT OF MARIJUANA DEPENDENCE. DRUG AND ALCOHOL DEPENDENCE, Vol. 105, no. 1-2 (2009), p. 132-138.
Ref.
164542
Tauwāhi:
SIIS R.854 Archivo
Palabras clave:
Cannabis, Drogas ilegales, Drogodependencias, Fármacos, Resultados, Tratamiento, EE.UU.
Cannabis, Drogas ilegales, Drogodependencias, Fármacos, Resultados, Tratamiento, EE.UU.
Ngā tūemi rite: A PLACEBO CONTROLLED TRIAL OF BUSPIRONE FOR THE TREATMENT OF MARIJUANA DEPENDENCE
- A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUSPIRONE FOR THE TREATMENT OF ANXIETY IN OPIOID-DEPENDENT INDIVIDUALS
- A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder
- Aripiprazole for the treatment of methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
- A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders
- RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUPROPION FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE
- RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BACLOFEN AND GABAPENTIN FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE